Fig. 5From: The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinomaIn vitro studies revealed that overexpression of HHLA could significantly increase the cellular migration abilities by using wound-healing assay and transwell assay. A and B The wound-healing assay revealed that in 786-O cells, after depletion of METTL3, overexpression of HHLA2 could significantly increase the cellular migration abilities (LV-METTL3-shRNA v.s. LV-METTL3-shRNA + LV-HHLA2OE, P < 0.01). C and D The wound-healing assay revealed that in ACHN cells, after depletion of METTL3, overexpression of HHLA2 could significantly increase the cellular migration abilities (LV-METTL3-shRNA v.s. LV-METTL3-shRNA + LV-HHLA2OE, P < 0.01). E and F The transwell assay results confirmed that, in both 786-O and ACHN cells, overexpression of HHLA2 could significantly increase the cellular invasion abilities (LV-METTL3-shRNA v.s. LV-METTL3-shRNA + LV-HHLA2OE, P < 0.01 respectively). Un-paired t test was used as needed. **P < 0.01, ***P < 0.001Back to article page